New Zealand markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
202.54+3.14 (+1.57%)
At close: 04:00PM EDT
203.48 +0.94 (+0.46%)
After hours: 06:35PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
10,819,500
10,981,700
13,444,600
14,377,900
13,452,900
Cost of revenue
2,385,500
2,109,700
1,805,200
1,955,400
1,816,300
Gross profit
8,434,000
8,872,000
11,639,400
12,422,500
11,636,600
Operating expenses
Research development
2,538,700
2,501,200
3,990,900
2,280,600
2,597,200
Selling general and administrative
2,714,200
2,674,300
2,504,500
2,374,700
2,106,300
Total operating expenses
5,924,400
6,064,000
7,193,100
5,386,800
5,635,800
Operating income or loss
2,509,600
2,808,000
4,446,300
7,035,700
6,000,800
Interest expense
255,000
253,600
222,500
187,400
200,600
Total other income/expenses net
-640,000
-820,200
781,700
157,600
-13,100
Income before tax
1,625,600
1,745,200
5,047,500
7,125,900
5,899,600
Income tax expense
133,900
52,500
992,300
1,158,000
1,425,600
Income from continuing operations
1,541,500
1,727,600
4,060,500
5,888,500
4,474,000
Net income
1,449,700
1,556,100
4,000,600
5,888,500
4,430,700
Net income available to common shareholders
1,449,700
1,556,100
4,000,600
5,888,500
4,430,700
Basic EPS
-
-
24.86
31.47
21.63
Diluted EPS
-
-
24.80
31.42
21.58
Basic average shares
-
-
160,900
187,100
204,900
Diluted average shares
-
-
161,300
187,400
205,300
EBITDA
-
2,880,100
5,734,800
7,993,900
7,116,800